DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR IRRIGATING SOLUTION G IN PLASTIC CONTAINER

« Back to Dashboard

All Clinical Trials for Irrigating Solution G In Plastic Container

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00333203	Next Generation Ophthalmic Irrigating Solution Posterior Segment Study	Completed	Alcon Research	Phase 3	2005-10-01	The purpose of this study is to evaluate the safety of Next Generation Ophthalmic Irrigating Solution (NGOIS) compared to BSS PLUS for use during surgery for removal of epimacular membrane and vitrectomy.
NCT00333268	Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus	Completed	Alcon Research	Phase 3	2004-09-01	The purpose of this study is to determine the safety and efficacy of Next Generation Ophthalmic Irrigating Solution (NGOIS) compared to BSS Plus for use during cataract extraction and intra-ocular lens (IOL) implantation.
NCT00346528	Safety of NGOIS Compared to BSS Plus in Pediatric Patients	Completed	Alcon Research	Phase 3	2006-07-01	To evaluate the Safety of Next Generation Ophthalmic Irrigating Solution compared to BSS Plus for use during cataract surgery in Pediatric patients.
NCT00588016	Concentration of Itraconazole Solution in Nasal Secretions	Completed	Mayo Clinic	Phase 1	2007-04-01	The primary objective of this study is to determine the concentration of itraconazole irrigation in nasal mucous specimens via collection and High-performance liquid chromatography (HPLC) assay. Eight (8) patients with chronic rhinosinusitis (CRS) and two (2) healthy controls will be enrolled in the initial evaluation. After an initial control nasal specimen, followed by seven days of twice daily topical itraconazole irrigation, nasal specimens will be collected at varying time intervals and the concentrations measured. The primary endpoint is development of a reliable collection and assay technique with concentration curves over time of topically administered itraconazole. A secondary endpoint is to determine if the concentrations measured achieve a mean inhibitory concentration (MIC90) to commonly cultured fungal species in the nose.

Clinical Trial Conditions for Irrigating Solution G In Plastic Container

Condition Name

Condition Name for Irrigating Solution G In Plastic Container
Intervention	Trials
Cataract	5
Dry Socket	1
Surgical Site Infection	1
Sinusitis	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Irrigating Solution G In Plastic Container
Intervention	Trials
Cataract	6
Pain, Postoperative	1
Eye Diseases	1
Dry Socket	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Irrigating Solution G In Plastic Container

Trials by Country

Trials by Country for Irrigating Solution G In Plastic Container
Location	Trials
United States	5
Canada	1
India	1
Turkey	1
Brazil	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Irrigating Solution G In Plastic Container
Location	Trials
Texas	3
Maryland	1
Minnesota	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Irrigating Solution G In Plastic Container

Clinical Trial Phase

Clinical Trial Phase for Irrigating Solution G In Plastic Container
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	3
Phase 2	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Irrigating Solution G In Plastic Container
Clinical Trial Phase	Trials
Completed	8
Active, not recruiting	1
Terminated	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Irrigating Solution G In Plastic Container

Sponsor Name

Sponsor Name for Irrigating Solution G In Plastic Container
Sponsor	Trials
Alcon Research	3
Johns Hopkins University	1
Attabib, Najmedden, M.D.	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Irrigating Solution G In Plastic Container
Sponsor	Trials
Other	10
Industry	3

Export unavailable in trial.
Subscribe for complete access.